CXCR3 and fetal growth restriction: CXCR3 interacts with its ligands to disrupt fetal-maternal immune tolerance, triggering a range of chronic inflammatory lesions in the placenta that lead to intrauterine growth restriction, fetal death, spontaneous abortion, premature rupture of membranes, and preterm delivery [23–25].